title: Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
abstract: BACKGROUND
  Recently revised American College of Cardiology/American Heart Association guidelines have suggested that exercise test scores be used in decisions concerning patients with suspected coronary artery disease (CAD). Pretest and exercise test scores derived for use in women without known CAD have not been tested in women with a low prevalence of CAD.
  
  
  METHODS
  Within the Women's Ischemia Syndrome Evaluation (WISE) study, we evaluated 563 women undergoing coronary angiography for suspected myocardial ischemia. The prevalence of angiographic CAD was 26%. Overall, 189 women underwent treadmill exercise testing. Prognostic end points included death, myocardial infarction, stroke, and revascularization.
  
  
  RESULTS
  Each score stratified women into 3 probability groups (P <.001) according to the prevalence of coronary disease: Pretest: low 20/164 (12%), intermediate 53/245 (22%), high 75/154 (49%); Exercise test: low 11/83 (13%), intermediate 22/74 (30%), high 17/32 (53%). However, the Duke score did not stratify as well: low 7/46 (15%), intermediate 36/126 (29%), high 6/17 (35%); P =.44. When pretest and exercise scores were considered together, the best stratification with the exercise test score was in the intermediate pretest group (P <.03). The Duke score did not stratify this group at all (P =.98). Pretest and exercise test scores also stratified women according to prognostic end points: pretest--low 7/164 (4.3%), intermediate 28/245 (11.4%), high 27/154 (17.5%), P <.01; exercise test--low 4/83 (4.8%) and intermediate-high 17/106 (16%), P =.014.
  
  
  CONCLUSIONS
  Both pretest and exercise test scores performed better than the Duke score in stratifying women with a low prevalence of angiographic CAD. The exercise test score appears useful in women with an intermediate pretest score, consistent with American College of Cardiology/American Heart Association guidelines.
authors.affiliation: Section of Cardiology, Department of Medicine, West Virginia University School of Medicine, Morgantown, WVa, USA. amorise@pol.net
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Morise
authors.forename: Marian B
authors.initials: MB
authors.lastname: Olson
authors.forename: C Noel Bairey
authors.initials: CN
authors.lastname: Merz
authors.forename: Sunil
authors.initials: S
authors.lastname: Mankad
authors.forename: William J
authors.initials: WJ
authors.lastname: Rogers
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Pepine
authors.forename: Steven E
authors.initials: SE
authors.lastname: Reis
authors.forename: Barry L
authors.initials: BL
authors.lastname: Sharaf
authors.forename: George
authors.initials: G
authors.lastname: Sopko
authors.forename: Karen
authors.initials: K
authors.lastname: Smith
authors.forename: Gerald M
authors.initials: GM
authors.lastname: Pohost
authors.forename: Leslee
authors.initials: L
authors.lastname: Shaw
mesh_terms: D017023:Coronary Angiography; D003327:Coronary Disease / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology*; D005080:Exercise Test / Q000592:standards*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D015995:Prevalence; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity